NuuVim Review

NuuVim review: cheap compounded GLP-1s, in a pill or a shot, if you can live with a thin paper trail

NuuVim is a young Texas direct-to-consumer telehealth program built around one clear promise: get you on compounded semaglutide or tirzepatide for as little as money as possible, with the same flat price no matter your dose. New GLP-1 users start at $79 a month for compounded semaglutide and a little more for tirzepatide, and — unusually — you can take either drug as an injection OR as an oral version. That combination of rock-bottom entry pricing and genuine oral access is the real reason to look at NuuVim. The catch is a lean trust profile: no named medical director, no surfaced refund policy, and a 2025 copyright that tells you this operation is brand new.

What the $79-a-month price actually buys

NuuVim runs a true flat-rate model — 'all doses, one low price, no extra fees,' in its own words. You are not nickeled with a separate consult charge or a dose-escalation surcharge, and free shipping is folded in. That matters because most compounding programs quietly raise your bill as your dose climbs; here the headline number is the number. The category median sits around $169 a month, so NuuVim's compounded semaglutide undercuts the typical competitor by a wide margin.

There is one wrinkle worth understanding before you sign up: the advertised price is the 'new GLP-1 user' rate. If you are already an established GLP-1 patient, NuuVim charges a higher 'current user' rate for the same drug. So the $79 figure is an introductory anchor tied to your status, not a permanent guarantee, and the full cost is only confirmed after you complete the intake evaluation.

Injection or pill — the differentiator most rivals can't match

The thing that genuinely sets NuuVim apart is oral access. Plenty of telehealth brands will sell you compounded semaglutide or tirzepatide in a vial; far fewer offer a compounded ORAL form of both drugs. If needles are the reason you've been putting off GLP-1 treatment, this is a meaningful door-opener. NuuVim lets you pick injectable or oral for either medication at the same flat price.

• Compounded semaglutide — injectable or oral, flat all-dose pricing for new users
• Compounded tirzepatide — injectable or oral, flat all-dose pricing for new users
• Brand-name Ozempic and Zepbound are also listed, but at four-figure monthly cash prices far above what the manufacturers' own self-pay channels charge

On the brand side, be careful. NuuVim does list real Ozempic and Zepbound, but the cash prices are steep — well over a thousand dollars a month, and meaningfully higher than buying through LillyDirect or NovoCare directly. If you specifically want FDA-approved brand-name medication, price it through the manufacturer first; NuuVim's value is in the compounded tier, not the brand tier.

How the medicine is dispensed

NuuVim doesn't run its own pharmacy. It names two outside compounding partners in its terms — Hallandale Pharmacy in Fort Lauderdale and Pharmacy Hub in Miami — both of which already appear as vetted facilities in our own pharmacy directory, which is a real point in NuuVim's favor. The company says it works only with physicians and licensed nurse practitioners, and medication ships directly from licensed US pharmacies. What it does NOT tell you is which pharmacy fills which drug or form, so you can't fully predict where your specific prescription originates.

The honest drawbacks

Two facts should temper your enthusiasm. First, these compounded GLP-1s are not FDA-approved — compounded preparations aren't evaluated by the FDA for safety, effectiveness, or quality the way Wegovy or Zepbound are. NuuVim also launched after the FDA wound down its compounding enforcement discretion for tirzepatide and semaglutide in 2025, which means the legality of ongoing compounded GLP-1 marketing rests on each pharmacy's patient-specific compounding exemption — something we cannot independently verify. Second, the company is thin on transparency where it counts.

• No founder, CEO, medical director, or pharmacist-in-charge is named anywhere on the site
• Refund and cancellation terms aren't surfaced before you buy
• A 2025 copyright means there's no multi-year track record to judge
• Its terms say service covers all 50 states plus DC, but warn 'some services may not be available' without saying which — so coverage in your state isn't guaranteed in writing

Who should choose NuuVim — and who should skip it

Choose NuuVim if you are a cash-pay patient hunting for the lowest realistic entry price on compounded GLP-1s, and especially if oral dosing is the feature that finally gets you started. The flat all-dose pricing is honest and the two named pharmacies are reputable facilities we already track. Skip it if you want brand-name medication (buy direct from the manufacturer instead), if you need the reassurance of a named medical director and a published refund policy, or if you're uneasy taking a non-FDA-approved compounded drug from a company with no track record yet.

Bottom line

NuuVim is a legitimate-looking, LegitScript-certified, HIPAA-compliant budget option with a standout feature — compounded semaglutide and tirzepatide available as a pill or a shot at a genuinely low flat rate. We rate our confidence in it as medium, not high: the operating company (NuuVim LLC) and its two pharmacy partners are disclosed and check out, but the missing leadership names, hidden refund terms, and reliance on FDA-unapproved compounded medication keep it short of a top trust tier. For a closer-priced, better-documented alternative, compare it against other low-cost programs using our scoring methodology before you commit.

If you're weighing alternatives, Sesame Care ($59/month) and bmiMD ($99/month) are among the closest options we track to NuuVim.